By DAVID SHAYWITZ Consumer health and wellness is experiencing a flurry of activity. The lab testing company Function (motto: “It’s time to own your health”) acquired Ezra, a whole body MRI company promising “the world’s most advanced longevity scan.” Oura, maker of the popular smart ring, recently added an integration for continuous glucose measurement as…
Patients at the five CommonSpirit hospitals in Utah will have access to the physicians and providers at University of Utah Health
WASHINGTON — Surrounded by hot pink lights and cherry blossom pink drapes on a ballroom stage, family doctor Marguerite Duane offered a seemingly simple solution to infertility: Doctors should have conversations with young girls about whether they want to have children one day. “I have these conversations with children starting at 8, 10, 12 years…
McMINNVILLE, Tenn. — Each month, Michelle Shaw went to a pain clinic to get the shots that made her back feel worse — so she could get the pills that made her back feel better. Shaw, 56, who has been dependent on opioid painkillers since she injured her back in a fall a decade ago,…
EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
By MATTHEW HOLT At some point I had to crawl out of my hole and put pen to paper on the election debacle that just took place, and what the ensuing lunacy might be like for the health care system. So this is my attempt to do just that. It’s really hard to understand why…
Beyond the branded products currently sold by Mallinckrodt and Endo, the companies say the combined business will also have a strong foundation in rare and orphan diseases. Generic medicines will be spun out as a separate company. The post Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal appeared first…
By embedding AI into primary care workflows, clinicians can validate their decisions and make more accurate and timely diagnoses, ensuring that patients receive the care they need without unnecessary delays. The post The Promise of AI in Enhancing Specialist-Level Diagnoses in Primary Care: Overcoming Adoption Barriers appeared first on MedCity News.
Tom Contos is an avid runner. When he started experiencing rectal bleeding in March, he thought exercise could be the cause and tried to ignore it. But he became increasingly worried when the bleeding continued for weeks. The Chicago health care consultant contacted his physician at Northwestern Medicine, who referred him for a diagnostic colonoscopy,…
Nura Bio aims to treat neurodegeneration with a small molecule designed to block SARM1, a novel target involved in axon degeneration. Following positive Phase 1 results in healthy volunteers, the startup is now preparing for mid-stage clinical testing. The post Neuro Startup Nura Bio Adds $68M to Spare Axons With Its Brain-Penetrating Drug appeared first…